pseudoporphyria bullous photosensitivity clinically histologically mimics porphyria cutanea difference abnormalities urine serum porphyrin noted laboratories pseudoporphyria reported patients chronic kidney failure treated hemodialysis excessive exposure ultraviolet uva tanning pseudoporphyria clinically characterized increased skin fragility erythema appearance tense bullae erosions sunexposed skin identical seen patients pct however clinical pearl may prove helpful differentiating pseudoporphyria pct classic features hypertrichosis hyperpigmentation sclerodermoid changes found pct unusual pseudoporphyria second clinical pattern pseudoporphyria similar presentation erythropoietic protoporphyria epp autosomal dominant porphyria resulting reduced activity ferrochelatasecitation needed contrast pct epp usually begins childhood history photosensitivity often described burning sensation immediately sunlight exposure clinically epp characterized erythema edema shallow scars waxy induration skin particularly face pseudoporphyria clinically mimics epp described almost exclusively children taking naproxen juvenile rheumatoid arthritis naproxeninduced pseudoporphyria seems dimorphic presentation pctlike pattern often seen adult population epplike pattern commonly seen children although overlap documented although pseudoporphyria predilection toward one race shown fairskinned children highly prone sunburn likely develop naproxeninduced pseudoporphyria children skin types iii higher wallace et al demonstrated even absence history blistering children light skin blue green eyes increased risk developing shallow scars face taking naproxen pseudoporphyria induced wide range medications excessive uva exposure hemodialysis one frequently reported drug naproxen frequent source uva exposure tanning booths recognition pseudoporphyria increases number new medications expands list etiologic agents associated pseudoporphyria likely continue grow agents associated pseudoporphyria precise pathophysiologic mechanism pseudoporphyria fully understood drugs especially non steroidal antiinflammatory drugs trigger pseudoporphyria presence ultraviolet light pathophysiology pseudoporphyria associated hemodialysis fully explained aluminum hydroxide implicated hemodialysisassociated pseudoporphyria aluminum hydroxide found dialysis solution shown produce porphyrialike disorder longterm administration rats sun avoidance avoidance tanning booths usage broad spectrum sunscreen blocks uva uvb identification avoidance offending drug although fewer cases documented english language literature pseudoporphyria likely underreported literature symptom condition eg side effect medicine symptom liver problems symptoms pseudoporhphyra names symptoms mentioned rarity porphyria modern times also makes use term pseudoporphyria obscure careful history utmost importance diagnosis pseudoporphyria considered personal family history hepatitis porphyria photosensitivity disorder must sought although genetic factor considered pseudoporphyria one case monozygotic twins developing pseudoporphyria excessive uva exposure longterm tanning bed use documented patient thoroughly questioned regarding symptoms connective tissue disorder may underlying pathology photosensitivity recent reports suggest connective tissue disorder may predisposing factor patients using nonsteroidal antiinflammatory drugs nsaids develop pseudoporphyria httpsenwikipediaorgwikipseudoporphyriacutaneatarda